Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -11,870 | -24,770 | -4,407 | -7,255 |
| Depreciation Amortization | 1,145 | 26,212 | 1,120 | 1,113 |
| Income taxes - deferred | -2,580 | 33 | N/A | -621 |
| Accounts receivable | -1 | 128 | -128 | N/A |
| Accounts payable and accrued liabilities | 470 | -436 | 293 | 424 |
| Other Working Capital | 1,393 | 457 | 436 | 421 |
| Other Operating Activity | 9,553 | -4,478 | -165 | 3,676 |
| Operating Cash Flow | $-1,890 | $-2,854 | $-2,851 | $-2,242 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | N/A | -18 | -276 |
| Purchase Of Investment | N/A | N/A | N/A | -65 |
| Other Investing Activity | 3 | 2 | 3 | -8 |
| Investing Cash Flow | $3 | $2 | $-15 | $-349 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 184 | 1,124 | 2,865 | 2,547 |
| Common Stock Issued | N/A | 3,726 | 0 | N/A |
| Other Financing Activity | -293 | 0 | 0 | 0 |
| Financing Cash Flow | $-109 | $4,850 | $2,865 | $2,547 |
| Beginning Cash Position | 1,999 | 1 | 2 | 46 |
| End Cash Position | 3 | 1,999 | 1 | 2 |
| Net Cash Flow | $-1,996 | $1,998 | $-1 | $-44 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,890 | -2,854 | -2,851 | -2,242 |
| Capital Expenditure | N/A | N/A | -18 | -276 |
| Free Cash Flow | -1,890 | -2,854 | -2,869 | -2,518 |